JP2022532947A - Ｃ－ｃモチーフケモカインリガンド１４の測定に基づく腎損傷の評価および処置のための方法 - Google Patents

Ｃ－ｃモチーフケモカインリガンド１４の測定に基づく腎損傷の評価および処置のための方法 Download PDF

Info

Publication number
JP2022532947A
JP2022532947A JP2021569931A JP2021569931A JP2022532947A JP 2022532947 A JP2022532947 A JP 2022532947A JP 2021569931 A JP2021569931 A JP 2021569931A JP 2021569931 A JP2021569931 A JP 2021569931A JP 2022532947 A JP2022532947 A JP 2022532947A
Authority
JP
Japan
Prior art keywords
renal
subject
acute
creatinine
injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021569931A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022532947A5 (https=
Inventor
パトリック カンプ，ジェームス
クウォン，トーマス
マクファーソン，ポール
Original Assignee
アスチュート メディカル，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アスチュート メディカル，インコーポレイテッド filed Critical アスチュート メディカル，インコーポレイテッド
Publication of JP2022532947A publication Critical patent/JP2022532947A/ja
Publication of JP2022532947A5 publication Critical patent/JP2022532947A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/521—Chemokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2021569931A 2019-05-24 2020-05-22 Ｃ－ｃモチーフケモカインリガンド１４の測定に基づく腎損傷の評価および処置のための方法 Pending JP2022532947A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962852961P 2019-05-24 2019-05-24
US62/852,961 2019-05-24
PCT/US2020/034400 WO2020243011A1 (en) 2019-05-24 2020-05-22 Methods for evaluation and treatment of renal injury based on c-c motif chemokine ligand 14 measurement

Publications (2)

Publication Number Publication Date
JP2022532947A true JP2022532947A (ja) 2022-07-20
JP2022532947A5 JP2022532947A5 (https=) 2023-05-30

Family

ID=73554165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021569931A Pending JP2022532947A (ja) 2019-05-24 2020-05-22 Ｃ－ｃモチーフケモカインリガンド１４の測定に基づく腎損傷の評価および処置のための方法

Country Status (7)

Country Link
US (1) US20220236285A1 (https=)
EP (1) EP3977118A4 (https=)
JP (1) JP2022532947A (https=)
CN (1) CN114207436A (https=)
AU (1) AU2020282321A1 (https=)
CA (1) CA3141817A1 (https=)
WO (1) WO2020243011A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025141825A (ja) * 2024-03-15 2025-09-29 台北医学大学 急性腎臓病予測方法及び予測システム

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021381364A1 (en) * 2020-11-18 2023-06-22 Astute Medical, Inc. Methods and compositions for treatment of renal injury and renal failure
US20220284243A1 (en) * 2021-03-03 2022-09-08 International Business Machines Corporation Ensemble voting classifiers using adjusted thresholds
WO2023168299A1 (en) * 2022-03-03 2023-09-07 Astute Medical, Inc. Methods and compositions for assessing and treating persistent acute kidney injury based on c-c motif chemokine ligand 14 measurement

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160146832A1 (en) * 2013-06-05 2016-05-26 Lakhmir S. Chawla Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2017533427A (ja) * 2014-10-20 2017-11-09 アスチュート メディカル，インコーポレイテッド 腎障害および腎不全の診断および予後のための方法および組成物
WO2018132702A1 (en) * 2017-01-12 2018-07-19 Astute Medical, Inc. Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11327082B2 (en) * 2017-09-13 2022-05-10 B.R.A.H.M.S Gmbh Proadrenomedullin as a marker for abnormal platelet levels

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160146832A1 (en) * 2013-06-05 2016-05-26 Lakhmir S. Chawla Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2017533427A (ja) * 2014-10-20 2017-11-09 アスチュート メディカル，インコーポレイテッド 腎障害および腎不全の診断および予後のための方法および組成物
WO2018132702A1 (en) * 2017-01-12 2018-07-19 Astute Medical, Inc. Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JEREMIAH R. BROWN: "Determinants of Acute Kidney Injury Duration After Cardiac Surgery: An Externally Validated Tool", ANN THORAC SURG, vol. 93, JPN6024003998, 2012, pages 570 - 576, ISSN: 0005255403 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025141825A (ja) * 2024-03-15 2025-09-29 台北医学大学 急性腎臓病予測方法及び予測システム

Also Published As

Publication number Publication date
CN114207436A (zh) 2022-03-18
EP3977118A4 (en) 2023-06-14
CA3141817A1 (en) 2020-12-03
EP3977118A1 (en) 2022-04-06
AU2020282321A1 (en) 2021-12-23
WO2020243011A1 (en) 2020-12-03
US20220236285A1 (en) 2022-07-28

Similar Documents

Publication Publication Date Title
US12590975B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US9696322B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2009313189B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2364370B1 (en) Methods for prognosis of acute renal failure
US12099067B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US9229010B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2740923A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2751435A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and failure
US20160123996A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20230038581A1 (en) Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
US20120052512A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2011311997A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2022532947A (ja) Ｃ－ｃモチーフケモカインリガンド１４の測定に基づく腎損傷の評価および処置のための方法
AU2011213685B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US12560616B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20170315134A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US11506672B2 (en) Follistatin-related protein 3 for diagnosis and prognosis of renal injury and renal failure
AU2015203814A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2015200547A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230522

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230522

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240131

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240206

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240903